Article Details

CiRC Biosciences Announces Orphan Drug Designation for Treatment of Retinitis Pigmentosa (RP)

Retrieved on: 2021-03-10 08:15:00

Tags for this article:

Click the tags to see associated articles and topics

CiRC Biosciences Announces Orphan Drug Designation for Treatment of Retinitis Pigmentosa (RP). View article details on hiswai:

Excerpt

... therapy and synthetic biology utilizing artificial intelligence. The company's current portfolio includes Castle Creek Biosciences, CiRC Biosciences, ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up